Cargando…

MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer

BACKGROUND: The study was designed to elucidate the association and functional roles of miR-26b-5p and c-MYC binding protein (MYCBP) in triple-negative breast cancer (TNBC). METHOD: Luciferase reporter assay was used to confirm the relationship between miR-26b-5p and MYCBP in TNBC cells. The express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Sugang, Wei, Hui, Wang, Chunyan, Han, Jixia, Chen, Xiumin, Li, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903572/ https://www.ncbi.nlm.nih.gov/pubmed/34895159 http://dx.doi.org/10.1186/s11658-021-00288-3

Ejemplares similares

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers
por: Liang, Jennifer, et al.
Publicado: (2018)

lncRNA LUNAR1 accelerates colorectal cancer progression by targeting the miR-495-3p/MYCBP axis
por: Qian, Jiajie, et al.
Publicado: (2020)

Non‐coding RNA MFI2‐AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR‐574‐5p/MYCBP axis
por: Li, Chenglong, et al.
Publicado: (2019)

Upregulation Of miR-153 Inhibits Triple-Negative Breast Cancer Progression By Targeting ZEB2-Mediated EMT And Contributes To Better Prognosis
por: Shi, Dongliang, et al.
Publicado: (2019)

miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
por: Kong, Peng, et al.
Publicado: (2018)

miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1
por: Li, Yuan, et al.
Publicado: (2021)

MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2
por: Shao, Ying, et al.
Publicado: (2016)

Overexpression of lncRNA TATDN1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Regulating miR-26b Methylation
por: Long, Quanyi, et al.
Publicado: (2020)

MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
por: Hou, Lingmi, et al.
Publicado: (2016)

miR-218 Inhibits Proliferation, Migration, and EMT of Gastric Cancer Cells by Targeting WASF3
por: Wang, Guojun, et al.
Publicado: (2017)

MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression
por: Yang, Zhi-Xue, et al.
Publicado: (2018)

MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
por: Wang, Cheng, et al.
Publicado: (2019)

CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019)

Transcriptionally regulated miR-26a-5p may act as BRCAness in Triple-Negative Breast Cancer
por: Zhang, Yue, et al.
Publicado: (2023)

Inhibition of miR-214 attenuates the migration and invasion of triple-negative breast cancer cells
por: Zhang, Yi, et al.
Publicado: (2019)

MiR‐552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression
por: Qu, Weiqing, et al.
Publicado: (2018)

MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells
por: Shi, Bingxia, et al.
Publicado: (2019)

MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer
por: Zhang, P, et al.
Publicado: (2017)

MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013)

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
por: Chen, Hua, et al.
Publicado: (2018)

miR-425 suppresses EMT and the development of TNBC (triple-negative breast cancer) by targeting the TGF-β 1/SMAD 3 signaling pathway
por: Liu, Yingping, et al.
Publicado: (2018)

Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT
por: Jin, Yujin, et al.
Publicado: (2019)

MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells
por: Zhang, Guochen, et al.
Publicado: (2020)

miR-199b-5p inhibits triple negative breast cancer cell proliferation, migration and invasion by targeting DDR1
por: Wu, Anhao, et al.
Publicado: (2018)

miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis
por: Williams, LaTanya V., et al.
Publicado: (2013)

EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β‐catenin at Ser552
por: Zhu, Xiao‐Xu, et al.
Publicado: (2019)

MiR-26a Promotes Ovarian Cancer Proliferation and Tumorigenesis
por: Shen, Wenjing, et al.
Publicado: (2014)

LncRNA BDNF‐AS inhibits proliferation, migration, invasion and EMT in oesophageal cancer cells by targeting miR‐214
por: Zhao, Huaying, et al.
Publicado: (2018)

MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG
por: An, Ning, et al.
Publicado: (2020)

Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013)

The Long Noncoding RNA LINC00665 Facilitates c-Myc Transcriptional Activity via the miR-195-5p MYCBP Axis to Promote Progression of Lung Adenocarcinoma
por: Wang, Anpeng, et al.
Publicado: (2021)

The role of miR-200b/c in balancing EMT and proliferation revealed by an activity reporter
por: Gollavilli, Paradesi Naidu, et al.
Publicado: (2021)

Delivery of miR-26a Using an Exosomes-Based Nanosystem Inhibited Proliferation of Hepatocellular Carcinoma
por: Mahati, Shaya, et al.
Publicado: (2021)

Inhibition of miR-483-5p improves the proliferation, invasion and inflammatory response of triple-negative breast cancer cells by targeting SOCS3
por: Ren, Jianbo, et al.
Publicado: (2021)

Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer
por: Lim, Sera, et al.
Publicado: (2020)

miR-19 Promotes Cell Proliferation, Invasion, Migration, and EMT by Inhibiting SPRED2-mediated Autophagy in Osteosarcoma Cells
por: Xie, Chuhai, et al.
Publicado: (2020)

Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer
por: Li, Yang, et al.
Publicado: (2017)

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021)

miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells
por: Liu, Chunhui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tonhbd7ocfmn44u8l9flhv7iip